Evidence for the involvement of TNF-α, IL-1β and IL-10 in the antinociceptive and anti-inflammatory effects of indole-3-guanylhydrazone hydrochloride, an aromatic aminoguanidine, in rodents.

作者: Silvia M.S. Sandes , Luana Heimfarth , Renan G. Brito , Priscila L. Santos , Daniele N. Gouveia

DOI: 10.1016/J.CBI.2018.02.026

关键词:

摘要: Abstract Background Indole-3-guanylhydrazone hydrochloride (LQM01) is a new derivative of aminoguanidine hydrochloride, an aromatic aminoguanidine. Methods Mice were treated with LQM01 (5, 10, 25 or 50 mg/kg, i.p.), vehicle (0.9% saline i.p.) standard drug. The mice subjected to carrageenan-induced pleurisy, abdominal writhing induced by acetic acid, the formalin test and hot-plate test. model non-inflammatory chronic muscle pain acid was also used. from protocol assessed for withdrawal threshold, strength motor coordination. evaluated Fos protein. Results inhibits TNF-α IL-1β production, as well leukocyte recruitment during inflammation process. level IL-10 in LQM01-treated increased pleural fluid. In addition, decreased nociceptive behavior test, (both phases) latency time on hot-plate. treatment mechanical hyperalgesia pain, no changes reduced number positive cells superficial dorsal horn. This compound exhibited antioxidant properties vitro assays. Conclusions has outstanding anti-inflammatory analgesic profile, probably mediated through reduction proinflammatory cytokines release, increase production neuron activity horn spinal cord mice. General significance Beneficial effects suggest that it some important clinical features can play role management ‘dysfunctional pain’ inflammatory diseases.

参考文章(85)
Massimo Locati, Alberto Mantovani, Antonio Sica, Macrophage Activation and Polarization as an Adaptive Component of Innate Immunity Development and Function of Myeloid Subsets. ,vol. 120, pp. 163- 184 ,(2013) , 10.1016/B978-0-12-417028-5.00006-5
Ramsin Benyamin, Rajive Adlaka, Andrea M Trescot, Scott E Glaser, Nalini Sehgal, Ricardo Vallejo, Ricardo Buenaventura, Sukdeb Datta, Opioid complications and side effects. Pain Physician. ,vol. 11, ,(2008) , 10.36076/PPJ.2008/11/S105
Yukinori Nagakura, Challenges in drug discovery for overcoming 'dysfunctional pain': an emerging category of chronic pain. Expert Opinion on Drug Discovery. ,vol. 10, pp. 1043- 1045 ,(2015) , 10.1517/17460441.2015.1066776
David Julius, Allan I. Basbaum, Molecular mechanisms of nociception Nature. ,vol. 413, pp. 203- 210 ,(2001) , 10.1038/35093019
K. O. Aley, Gordon McCarter, Jon D. Levine, Nitric Oxide Signaling in Pain and Nociceptor Sensitization in the Rat The Journal of Neuroscience. ,vol. 18, pp. 7008- 7014 ,(1998) , 10.1523/JNEUROSCI.18-17-07008.1998
S. T. Meller, G. F. Gebhart, Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain. ,vol. 52, pp. 127- 136 ,(1993) , 10.1016/0304-3959(93)90124-8
Henry L. Allen, Arthur Wase, W. T. Bear, Indomethacin and Aspirin: Effect of Nonsteroidal Anti-Inflammatory Agents on the Rate of Fracture Repair in the Rat Acta Orthopaedica Scandinavica. ,vol. 51, pp. 595- 600 ,(1980) , 10.3109/17453678008990848
P LUCCARINI, A CHILDERIC, A GAYDIER, D VOISIN, R DALLEL, The orofacial formalin test in the mouse: a behavioral model for studying physiology and modulation of trigeminal nociception. The Journal of Pain. ,vol. 7, pp. 908- 914 ,(2006) , 10.1016/J.JPAIN.2006.04.010